12月23日，截至港股收盘，恒生指数上涨0.82%，报19883.13点。中国抗体-B（03681.HK）收报1.09港元/股，上涨3.81%，成交量300股，成交额327港元，振幅0.0%。最近一个月来，中国抗体-B累计跌幅9.48%，今年来累计跌幅37.5%，跑输恒生指数15.68%的涨幅。财务数据显示，截至2024年6月30日，中国抗体-B实现营业总收入202.6万元，同比增长48.42%；...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.